Securities code: 688670 securities abbreviation: Jiangsu Gdk Biological Technology Co.Ltd(688670) Announcement No.: 2022-004
Jiangsu Gdk Biological Technology Co.Ltd(688670)
Announcement of resolutions of the 10th meeting of the first board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of supervisors
The notice of the 10th meeting of the first board of supervisors of Jiangsu Gdk Biological Technology Co.Ltd(688670) (hereinafter referred to as “the company”) was delivered by e-mail on February 21, 2022 and held by communication on February 25, 2022. The meeting was presided over by Mr. Wei Dachang, chairman of the board of supervisors. There were 3 supervisors who should attend the meeting and 3 supervisors who actually participated in the voting. The convening and convening of this meeting comply with the relevant provisions of the company law of the people’s Republic of China and the articles of association.
2、 Deliberation at the meeting of the board of supervisors
After deliberation by the attending supervisors, the following resolutions are made:
(I) deliberation and approval of the proposal on changes in accounting estimates
The board of supervisors of the company believes that the change of accounting estimates of the company complies with the relevant provisions of the accounting standards for business enterprises and the actual operation of the company, can more objectively and fairly reflect the financial status and operating results of the company, and there is no situation that damages the interests of the company and all shareholders, especially the interests of small and medium-sized shareholders. The relevant decision-making procedures comply with the relevant provisions of the company law of the people’s Republic of China and other laws and regulations and the articles of association, and agree to the change of accounting estimates.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Disclosure of Jiangsu Gdk Biological Technology Co.Ltd(688670) announcement on changes in accounting estimates (Announcement No.: 2022-002).
Voting results: 3 affirmative votes, 0 negative votes and 0 abstention votes.
(II) deliberated and passed the proposal on the provision for asset impairment in 2021
The board of supervisors of the company believes that the provision for asset impairment this time is in line with the accounting standards for business enterprises and relevant accounting policies of the company and the actual situation of the company. After the provision for inventory depreciation and impairment is made, it can more objectively and fairly reflect the company’s financial status and operating results; The decision-making procedure for the provision for impairment is standardized, in line with the provisions of laws and regulations and the articles of association, and there is no situation that damages the interests of the company and all shareholders. The company agrees to withdraw the provision for asset impairment this time.
See the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) for details The Jiangsu Gdk Biological Technology Co.Ltd(688670) announcement on the provision for asset impairment in 2021 (Announcement No.: 2022-003) disclosed.
Voting results: 3 affirmative votes, 0 negative votes and 0 abstention votes.
It is hereby announced.
Jiangsu Gdk Biological Technology Co.Ltd(688670) board of supervisors February 26, 2022
